APDN
Income statement / Annual
Last year (2023), Applied DNA Sciences, Inc.'s total revenue was $13.37 M,
a decrease of 26.43% from the previous year.
In 2023, Applied DNA Sciences, Inc.'s net income was -$9.95 M.
See Applied DNA Sciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
09/30/2015 |
09/30/2014 |
| Operating Revenue |
$13.37 M
|
$18.17 M
|
$9.03 M
|
$1.93 M
|
$5.39 M
|
$3.90 M
|
$4.75 M
|
$4.19 M
|
$9.01 M
|
$2.72 M
|
| Cost of Revenue |
$7.83 M |
$13.12 M |
$4.10 M |
$720,900.00 |
$877,613.00 |
$1.21 M |
$1.08 M |
$746,582.00 |
$384,269.00 |
$0.00 |
| Gross Profit |
$5.53 M |
$5.05 M |
$4.93 M |
$1.21 M |
$4.51 M |
$2.70 M |
$3.67 M |
$3.44 M |
$8.62 M |
$2.72 M |
| Gross Profit Ratio |
0.41 |
0.28 |
0.55 |
0.63 |
0.84 |
0.69 |
0.77 |
0.82 |
0.96 |
1 |
| Research and Development
Expenses |
$3.74 M
|
$3.93 M
|
$3.77 M
|
$3.32 M
|
$2.97 M
|
$2.75 M
|
$2.28 M
|
$3.69 M
|
$1.64 M
|
$1.30 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$11.04 M
|
$13.32 M
|
$11.24 M
|
$14.74 M
|
$13.25 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$12.75 M
|
$15.10 M
|
$12.61 M
|
$10.14 M
|
$10.28 M
|
$11.04 M
|
$13.32 M
|
$11.24 M
|
$14.74 M
|
$13.25 M
|
| Other Expenses |
$0.00 |
-$1.72 M |
$844,438.00 |
$285,730.00 |
$390,424.00 |
-$37,005.00 |
-$38,388.00 |
$12,875.00 |
-$28,313.00 |
$123,914.00 |
| Operating Expenses |
$16.49 M |
$19.02 M |
$17.22 M |
$13.75 M |
$13.64 M |
$14.34 M |
$16.49 M |
$15.64 M |
$16.86 M |
$14.99 M |
| Cost And Expenses |
$24.32 M |
$32.14 M |
$21.32 M |
$14.47 M |
$14.51 M |
$15.55 M |
$17.57 M |
$16.39 M |
$16.86 M |
$14.99 M |
| Interest Income |
$75,332.00 |
$7,200.00 |
$13,675.00 |
$115,830.00 |
$162,432.00 |
$0.00 |
$2,763.00 |
$0.00 |
$8,407.00 |
$846.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$115,830.00 |
$162,432.00 |
$9,615.00 |
$35,625.00 |
$0.00 |
$4.03 M |
$795,120.00 |
| Depreciation &
Amortization |
$1.36 M
|
$1.29 M
|
$844,438.00
|
$285,730.00
|
$390,424.00
|
$547,796.00
|
$633,328.00
|
$706,496.00
|
$490,641.00
|
$442,262.00
|
| EBITDA |
-$9.59 M
|
-$12.68 M
|
-$11.68 M
|
-$12.25 M
|
-$8.06 M
|
-$11.10 M
|
-$11.93 M
|
-$11.49 M
|
-$7.36 M
|
-$11.83 M
|
| EBITDA Ratio |
-0.72 |
-1.18 |
-1.07 |
-6.54 |
-1.39 |
-2.85 |
-2.51 |
-2.75 |
-0.38 |
-4.01 |
| Operating Income Ratio
|
-0.82
|
-0.77
|
-1.36
|
-6.49
|
-1.69
|
-2.98
|
-2.7
|
-2.91
|
-0.87
|
-4.51
|
| Total Other
Income/Expenses Net |
$930,374.00
|
$5.70 M
|
-$1.75 M
|
-$493,905.00
|
$506,825.00
|
-$46,620.00
|
-$289,602.00
|
$23,879.00
|
-$4.03 M
|
-$795,120.00
|
| Income Before Tax |
-$10.02 M |
-$8.27 M |
-$14.28 M |
-$13.03 M |
-$8.62 M |
-$11.69 M |
-$12.86 M |
-$12.18 M |
-$11.88 M |
-$13.07 M |
| Income Before Tax Ratio
|
-0.75
|
-0.46
|
-1.58
|
-6.75
|
-1.6
|
-3
|
-2.71
|
-2.91
|
-1.32
|
-4.8
|
| Income Tax Expense |
$0.00 |
$107,937.00 |
$1.75 M |
-$263,930.00 |
$15,000.00 |
$46,620.00 |
$289,602.00 |
-$23,879.00 |
$8.00 M |
$1.70 M |
| Net Income |
-$9.95 M |
-$8.38 M |
-$16.03 M |
-$12.76 M |
-$8.63 M |
-$11.69 M |
-$12.86 M |
-$12.18 M |
-$11.88 M |
-$13.07 M |
| Net Income Ratio |
-0.74 |
-0.46 |
-1.78 |
-6.61 |
-1.6 |
-3 |
-2.71 |
-2.91 |
-1.32 |
-4.8 |
| EPS |
-15.21 |
-18.68 |
-46.35 |
-65.14 |
-187.3 |
-317.12 |
-389.88 |
-411.13 |
-501.89 |
-773.45 |
| EPS Diluted |
-15.21 |
-18.68 |
-46.35 |
-65.14 |
-187.3 |
-317.12 |
-389.88 |
-411.13 |
-501.89 |
-773.45 |
| Weighted Average Shares
Out |
$653,771.00
|
$448,385.00
|
$345,850.00
|
$195,954.00
|
$46,090.00
|
$36,872.00
|
$32,974.00
|
$29,616.00
|
$23,673.00
|
$16,894.00
|
| Weighted Average Shares
Out Diluted |
$653,771.00
|
$448,385.00
|
$345,850.00
|
$195,954.00
|
$46,090.00
|
$36,872.00
|
$32,974.00
|
$29,616.00
|
$23,673.00
|
$16,894.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
